Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE Green Cures & Botanical Distribution Inc
WINNETKA, Calif., June 26, 2014 /PRNewswire/ -- Green Cures & Botanical Distribution Inc (OTC Pink: GRCU) ("Green Cures") announced today that it has formed a Product Research & Development Advisory Committee, which will assist the company in the research and development of additional the products to be introduced to the public under different brand names, discussed plans for additional products and brands, highlighted the recent Marijuana Business and Education EXPO, and provided a corporate update.
Effective today, the new Product Research & Development Advisory Committee will begin assisting Green Cures in the explanation and presentation to the public of potential benefits of certain of its upcoming products. The Advisory Committee will also assist Green Cures in the sourcing and selecting of additional high quality raw materials available in the market today, which Green Cures will use in the development of additional products to be introduced to the public in the near future.
Green Cures' Advisory Committee is being headed by Dr. Gerry Bedore, who was a co-founder of Socrates Distance Learning Technology Group. He is recognized for developing many of the most successful online higher education programs in the world today. As a Horticulturist for the State of Georgia, Dr. Bedore was recognized for his expertise in entomology and pathology in the care of plant life. Dr. Bedore has authored one book, co-authored two others, and has served as a research chair and committee member for over 200 studies in education, psychology, and business disciplines. Green Cures management anticipates bringing on additional members of the Advisory Committee in the near future to provide additional expertise, background, and business experience in the markets in which Green Cures operates.
Management of Green Cures is also pleased to announce that it plans to introduce, both under its own brands and labels currently under exclusive licensing, a minimum of 30 potential nutritional and medicinal cannabis derived products by the end of 4th quarter of 2014. In connection with the introduction of these new products, Management plans to continue to focus on branding, marketing, offering higher quality products than the competitors with more accessible pricing, and growing distribution channels. Green Cures Management will provide additional updates of its business strategies and progress as material events become available.
Finally, Green Cures announced that during the International Cannabis Association's recent Cannabis Business and Education EXPO in Las Vegas, Nevada, Green Cures was honored with the opportunity of presenting some of its current cannabis derived products to numerous cannabis industry advocates and lawmakers. While at the EXPO, Green Cures received substantial positive feedback and great interest in its products by the public.
In closing, Green Cures Management anticipates that its CBD Capsules will become available for sale in the very near future. Green Cures will provide additional information as it becomes available.
About Green Cures & Botanical Distribution Inc: (www.gcbdinc.com) (GRCU) operates a diverse portfolio of services and products within the botanical and medical cannabis industry, as permitted by law. The products include nutritional supplements, vitamins, minerals, herbs/botanicals, sports nutrition, and specialty products. In the rapidly growing industries of alternative care and medicinal products, GRCU also provides to the online community portals that supply information and resources regarding the benefits of cannabis-derived products.
FDA Statement: The statements contained in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.
Forward-looking statement: This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Forward-looking statements are identified by wording such as "scheduled (future sense)" "intend(s)", "plan(s)" "expect(s)", "believe(s)" "will" "estimate(s)", "anticipate(s)", "expect(s)", "may", "would", "could" or "should" or, in each case, the negative thereof, other variations thereon, or comparable terminology that implies anticipated future deliverables. The Company disclaims any obligation or intention to update any forward-looking statement for any reason.
©2012 PR Newswire. All Rights Reserved.